Key Record Dates
ClinicalTrials.gov Identifier: | NCT03075423 |
---|---|
Brief Title: | Randomized Phase-II Study of Nivolumab Plus Ipilimumab vs. Standard of Care in Untreated and Advanced Non-clear Cell RCC (SUNIFORECAST) |
First Submitted : | March 6, 2017 |
First Submitted that Met QC Criteria : | March 6, 2017 |
First Posted : | March 9, 2017 |
Last Update Submitted that Met QC Criteria : | May 29, 2020 |
Last Update Posted : | June 2, 2020 |